AU2003249344A1 - Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives - Google Patents

Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives Download PDF

Info

Publication number
AU2003249344A1
AU2003249344A1 AU2003249344A AU2003249344A AU2003249344A1 AU 2003249344 A1 AU2003249344 A1 AU 2003249344A1 AU 2003249344 A AU2003249344 A AU 2003249344A AU 2003249344 A AU2003249344 A AU 2003249344A AU 2003249344 A1 AU2003249344 A1 AU 2003249344A1
Authority
AU
Australia
Prior art keywords
alkyl
optionally substituted
heteroaryl
groups
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003249344A
Other languages
English (en)
Inventor
Rick J. Imbordino
Michael R. Reeder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co LLC filed Critical Pharmacia and Upjohn Co LLC
Publication of AU2003249344A1 publication Critical patent/AU2003249344A1/en
Assigned to PHARMACIA AND UPJOHN COMPANY LLC reassignment PHARMACIA AND UPJOHN COMPANY LLC Amend patent request/document other than specification (104) Assignors: PHARMACIA AND UPJOHN COMPANY
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
AU2003249344A 2002-06-20 2003-06-20 Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives Abandoned AU2003249344A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US60/390,285 2002-06-20
US45047803P 2003-02-27 2003-02-27
US60/450,478 2003-02-27
PCT/US2003/019585 WO2004000821A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives

Publications (1)

Publication Number Publication Date
AU2003249344A1 true AU2003249344A1 (en) 2004-01-06

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003249344A Abandoned AU2003249344A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives

Country Status (17)

Country Link
US (2) US7115747B2 (https=)
EP (1) EP1532123B1 (https=)
JP (1) JP2005533811A (https=)
CN (1) CN1324017C (https=)
AT (1) ATE370131T1 (https=)
AU (1) AU2003249344A1 (https=)
BR (1) BR0312439A (https=)
CA (1) CA2489988A1 (https=)
CO (1) CO5670350A2 (https=)
DE (1) DE60315664D1 (https=)
EA (1) EA008389B1 (https=)
IL (1) IL165763A0 (https=)
MX (1) MXPA04012630A (https=)
NO (1) NO20045497L (https=)
NZ (1) NZ537390A (https=)
PL (1) PL374999A1 (https=)
WO (1) WO2004000821A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351738B2 (en) * 2002-11-27 2008-04-01 Elan Pharmaceuticals, Inc. Substituted ureas and carbamates
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
US7872009B2 (en) * 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
WO2007061670A1 (en) 2005-11-21 2007-05-31 Amgen Inc. Beta-secretase modulators and methods of use
US7838676B2 (en) 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
US7745484B2 (en) 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
US20080277393A1 (en) * 2007-05-07 2008-11-13 True Charles W Collapsible, stackable, semi-rigid universal cotainer for hazardous and non-hazardous goods
US8163909B2 (en) 2007-05-25 2012-04-24 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
CA2687608C (en) 2007-05-25 2013-07-02 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
CA2736130C (en) 2008-09-11 2014-01-14 Amgen Inc. Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
EP2504330A1 (en) 2009-11-23 2012-10-03 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
US9296698B2 (en) 2009-11-23 2016-03-29 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
AU2011207679B2 (en) 2010-01-19 2013-10-10 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
MX2012010657A (es) 2010-03-15 2013-02-07 Amgen Inc Compuestos de espiro amino-dihidrooxazina y amino-dihidrotiazina como moduladores de beta-secretasa y su uso medico.
EP2547685A1 (en) 2010-03-15 2013-01-23 Amgen Inc. Spiro-tetracyclic ring compounds as beta - secretase modulators
EP2673279A1 (en) 2011-02-07 2013-12-18 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
WO2014078314A1 (en) 2012-11-15 2014-05-22 Amgen Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
CA2462851A1 (en) * 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
NZ533107A (en) * 2001-11-08 2007-04-27 Upjohn Co N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
EA008389B1 (ru) 2007-04-27
EP1532123A1 (en) 2005-05-25
WO2004000821A1 (en) 2003-12-31
CN1662510A (zh) 2005-08-31
JP2005533811A (ja) 2005-11-10
BR0312439A (pt) 2005-05-10
CN1324017C (zh) 2007-07-04
CA2489988A1 (en) 2003-12-31
US20040063965A1 (en) 2004-04-01
NZ537390A (en) 2006-07-28
DE60315664D1 (de) 2007-09-27
NO20045497L (no) 2005-03-07
ATE370131T1 (de) 2007-09-15
EP1532123B1 (en) 2007-08-15
CO5670350A2 (es) 2006-08-31
US20070105921A1 (en) 2007-05-10
EA200401510A1 (ru) 2005-06-30
PL374999A1 (en) 2005-11-14
NO20045497D0 (no) 2004-12-16
US7115747B2 (en) 2006-10-03
IL165763A0 (en) 2006-01-15
HK1081543A1 (zh) 2006-05-19
MXPA04012630A (es) 2005-09-30

Similar Documents

Publication Publication Date Title
AU2003249344A1 (en) Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives
KR102238179B1 (ko) 아비박탐의 간단한 제조방법
JPH0610191B2 (ja) ピロリドン誘導体の製造方法
CN110357801A (zh) 一种碘催化三组分反应合成含氮五元杂环化合物的方法
CN111675672A (zh) 一种制备阿塔鲁伦的方法
KR20050019766A (ko) 5-(1,3-옥사졸-2-일)벤조산 유도체의 제조 방법
WO1998032736A1 (en) Process for producing benzylsuccinic acid derivatives
CN114736186B (zh) 一种由氨基甲酸叔丁酯合成维兰特罗中间体的方法
CN119735562B (zh) 一种噁唑啉类化合物的合成方法
CN116375703B (zh) 一种阿哌沙班的合成工艺
SU399138A1 (ru) Способ получения 17-азастероидов
JP2022035954A (ja) N-Boc-ラクタム誘導体及びその製造方法、並びに、環状アミン誘導体の製造方法
JP2007320930A (ja) フェニルテトラゾール誘導体の製造法
CN101128449A (zh) 制备多西他赛的方法
JP2025141611A (ja) チオラクトン誘導体の製造方法
CN120329233A (zh) 乌帕替尼中间体的制备方法及其中间体
US3314974A (en) Thienyl-1-naphthalene acetic acids and related compounds
JPH0347269B2 (https=)
CN100378080C (zh) 赖诺普利类化合物的前体及其合成方法
JP2025062330A (ja) グルコンアミド誘導体の製造方法
JPS6259707B2 (https=)
JPH0577670B2 (https=)
KR20030055304A (ko) 보호된 1-(1-아미노알킬)-옥시란의 제조 방법
JPS6259106B2 (https=)
JPH0569831B2 (https=)

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE APPLICANT FROM PHARMACIA AND UPJOHN COMPANY TO PHARMACIA AND UPJOHN COMPANY LLC.

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application